未知或未特指的精神活性物质所致焦虑障碍
Anxiety disorder induced by unknown or unspecified psychoactive substance
- 层级
- 6 级
定义
未知或未特指的精神活性物质所致焦虑障碍的特征是在服用或停用未知或未特指精神活性物质期间或之后不久出现焦虑症状(如忧虑或担心、恐惧、过度自主神经觉醒状态的生理症状、回避行为)。原发性精神障碍(如焦虑和恐惧相关障碍、伴有突出焦虑症状的抑郁障碍)不能更好地解释这些症状,如果焦虑症状出现在使用未知或未特指精神活性物质之前,则可能属于这种情况、在停止使用未知或未特指的精神活性物质或戒断未知或未特指的精神活性物质后,症状仍持续相当长时间,或有其他证据表明之前已存在伴有焦虑症状的原发性精神障碍(例如,与使用该未知或未特指精神活性药物无关的既往发作史)。
Anxiety disorder induced by unknown or unspecified psychoactive substance is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from an unknown or unspecified psychoactive substance. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the unknown or unspecified psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the use of the unknown or unspecified psychoactive substance or withdrawal from the unknown or unspecified psychoactive substance, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the unknown or unspecified psychoactive substance).
索引词 可用于检索该条目的同义词与别名
- 未知或未特指的精神活性物质所致焦虑障碍
英文词条(1)
- Anxiety disorder induced by unknown or unspecified psychoactive substance
后组配轴 Postcoordination
后组配是在主干编码之后追加的可选扩展轴(如侧别、具体解剖部位、严重程度),用于把「部位 + 侧别 + 病程」等细节一次表达完整。只有标注「必填」的轴在组合编码时必须给出,其余可留空。
- 相关疾患associatedWith可选
- 病因hasCausingCondition必填